Recombinant chimeric anti-CD20 monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant chimeric anti-CD20 monoclonal antibody, covering 2014-08-01 to 2014-08-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma. [Phase 1]